Onexton FDA Approval History
FDA Approved: Yes (First approved November 25, 2014)
Brand name: Onexton
Generic name: benzoyl peroxide and clindamycin phosphate
Dosage form: Gel
Company: Bausch Health Companies Inc.
Treatment for: Acne
Onexton (benzoyl peroxide and clindamycin phosphate) is an antimicrobial and lincosamide antibacterial combination for the once-daily topical treatment of acne vulgaris.
Development timeline for Onexton
| Date | Article |
|---|---|
| Nov 25, 2014 | Approval Valeant Pharmaceuticals Announces FDA Approval of Onexton Gel for Acne Vulgaris |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
